Early Viral Dynamics Predict HIV Post-Treatment Control After Analytic Treatment Interruption
Gesham Magombedze,Elena Vendrame,Devi SenGupta,Romas Geleziunas,Susan Little,Davey Smith,Bruce Walker,Jean-Pierre Routy,Frederick M Hecht,Tae-Wook Chun,Michael Sneller,Jonathan Z Li,Steven G Deeks,Michael J Peluso
DOI: https://doi.org/10.1093/infdis/jiae551
2024-11-10
The Journal of Infectious Diseases
Abstract:A key research priority for developing an HIV cure strategy is to define the viral dynamics and biomarkers associated with sustained post-treatment control. The ability to predict the likelihood of sustained post-treatment control or non-control could minimize the time off antiretroviral therapy (ART) for those destined to not control and anticipate longer periods off ART for those destined to control. Mathematical modeling and machine learning were used to characterize virologic predictors of long-term virologic control using viral kinetics data from several studies in which participants interrupted ART. Predictors of post-ART outcomes were characterized using data accumulated from the time of treatment interruption, replicating real-time data collection in a clinical study, and classifying outcomes as either post-treatment control (plasma viremia ≤400 copies/mL at 2 of 3 time points for ≥24 weeks) or non-control. Potential predictors of virologic control were the time to rebound, the rate of initial rebound, and the peak plasma viremia. We found that people destined to be non-controllers could be identified within 3 weeks of rebound (prediction scores: accuracy, 80%; sensitivity, 82%; specificity, 71%). Given the widespread use of analytic treatment interruption in cure-related trials, these predictors may be useful to increase the safety of analytic treatment interruption through the early identification of people who are unlikely to become post-treatment controllers.
immunology,infectious diseases,microbiology